
Dr. Matthew D Hellmann MD
Hematologist-Oncologist | Hematology & Oncology
Massachusetts General Hospital 55 Fruit Street Boston MA, 02114About
I am a medical oncologist who specializes in the care of patients with lung cancers, particularly non small-cell lung cancers. I am dedicated to identifying better treatments for people with all stage ...
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
- Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
- ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology.
- Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer.
- 'Genotype/immunotype' correlations in resected NSCLC.
- Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab.
- Reply to M. Nishino et al.
- Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
- Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
- Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.
- Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
- Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Clinical Trials
- Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
- A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
- Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
- Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs
Treatments
- Lung Cancer, Immunotherapy, Clinical Trials
Dr. Matthew D Hellmann MD's Practice location
Practice At Massachusetts General Hospital 55 Fruit Street
Massachusetts General Hospital 55 Fruit Street -Boston, MA 02114Get Direction
Dr. Matthew D Hellmann MD's reviews
Write ReviewPatient Experience with Dr. Hellmann
Recommended Articles
- The Blow Self-Image Can Take During Lymphoma Treatment
Many who have endured cancer treatment experience a blow to their self image, and cease to recognize the person looking back at them in the mirror.However, it does not have to be that way! Here are some of the most common changes, and how to cope with them.Skin changesYou may begin to see your skin...
- The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
- Treatment Options of Multiple Myeloma
A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...
- The Effect of Sunshine on Lymphoma
Having a lack of enough vitamin D can drastically effect one's ability to fight many cancers, including lymphoma. So, researchers inevitably wondered whether the addition of Vitamin D to preexisting therapies would prolong patients' lives. The Wilmot Cancer Institute received a $3 million grant for...
- The Link Between Melatonin and Lymphoma
There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...
- Inspirational Blood Cancer Survivors
Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...
Nearby Providers
- Dr. YongLi Ji M.D. , PH.D.55 Fruit St Boston MA 02114
- Dr. Bruno Bastos M.D.44 Binney St Boston MA 02115
- Dr. Gary M. Strauss M.D.18 Acron Road Brookline Massachusetts 2445
- Prabhsimranjot Singh MD17 Faxon St Newton Massachusetts 02458
- Dr. Folefac Edmund M.D.79-81 Highland Ave. Salem MA 01970
- Dr. Susan Tinsley Schumer Other2014 Washington Street Newton Lower Falls MA 02462
Nearest Hospitals
MASSACHUSETTS EYE AND EAR INFIRMARYl
243 CHARLES STREET BOSTON MA 2114SHRINERS' HOSPITAL FOR CHILDREN - BOSTON, THEl
51 BLOSSOM STREET BOSTON MA 2114TUFTS MEDICAL CENTERl
800 WASHINGTON STREET BOSTON MA 2111